Similar articles

• [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].

  Kroneberg G, Schlossmann K, Stoepel K. Kroneberg G, et al. Arzneimittelforschung. 1967 Feb;17(2):199-207. Arzneimittelforschung. 1967. PMID: 5631784 German. No abstract available.
• Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.

  Botton I, Kinnard WJ, Buckley JP. Botton I, et al. J Pharmacol Exp Ther. 1966 May;152(2):243-50. J Pharmacol Exp Ther. 1966. PMID: 5944368 No abstract available.
• [Experimental studies with a new radiation protective agent].

  Szirmai E, Berkada B, Hajdukovic S, López-González JM. Szirmai E, et al. Arzneimittelforschung. 1968 May;18(5):625-8. Arzneimittelforschung. 1968. PMID: 4387834 German. No abstract available.
• [Pharmacological and biochemical effects of hydralazine and dihydralazine].

  van Zwieten PA. van Zwieten PA. Arzneimittelforschung. 1968 Jan;18(1):79-84. Arzneimittelforschung. 1968. PMID: 4386976 Review. German. No abstract available.
• Physiology and pharmacology of cardiac histamine.

  Mannaioni PF. Mannaioni PF. Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196:64-7. Arch Int Pharmacodyn Ther. 1972. PMID: 4115299 Review. No abstract available.